Miami Lakes, Florida
Phase II-IV research capability
Multi-specialty investigators, South Florida patient access, clinical sample processing, monitored storage, and coordinated imaging access.
View Miami LakesOne network. Two established research sites.
Clinical research built around access, expertise, and execution.
Wellness Clinical Research connects sponsors and CROs with bilingual, multi-specialty research teams in Miami Lakes, Florida and Vega Baja, Puerto Rico.
2 locationsFlorida and Puerto Rico
10 investigatorsMulti-specialty clinical expertise
Phase I-IVNetwork research capability
English + SpanishBilingual participant support
2 to 4 weeksAverage study startup time
Choose your path
Research partnerships and opportunities start here
Sponsors & CROs
Explore site capabilities, investigators, patient access, startup support, quality, and our coordinated network model.
Why WellnessParticipants
Learn how clinical trials work, what protects your safety, what to expect, and which studies are enrolling.
Explore participationPhysicians
Refer an appropriate patient or explore collaboration with a local research team that respects continuity of care.
Physician resourcesWhy Wellness
A site partner designed to keep studies moving
Both WCR sites operate within established private-practice environments, combining direct patient access and physician referral pathways with dedicated research teams and centralized coordination.
- Realistic feasibility centered on investigator fit and patient access
- Coordinated regulatory, contract, budget, central IRB, and training activities
- Study-specific recruitment and bilingual participant engagement
- Standardized procedures and responsive sponsor communication
Network advantage
One relationship, two distinct markets
Place opportunities in Miami, Vega Baja, or both through one coordinated research organization.
MiamiPhase II-IV
Vega BajaPhase I-IV
SharedNetwork coordination
Our locations
Established sites rooted in the communities they serve
Each location combines dedicated research operations with access to established medical practices, local patient populations, and bilingual support.
Vega Baja, Puerto Rico
Phase I-IV research capability
Community-based patient access, on-site laboratory workspace, infusion and observation capability, monitored storage, and coordinated imaging access.
View Vega BajaTherapeutic expertise
Broad clinical experience across common and specialty indications
Our investigator network spans gastroenterology, metabolic disease, dermatology, cardiology, pediatrics, vaccines, respiratory disease, neurology, and more.
Recruitment and retention
Participant access supported by relationships
Established practice populations, physician referrals, community outreach, digital campaigns, bilingual call support, and consistent follow-up form the foundation of our study-specific recruitment approach.
Explore recruitment capabilitiesOperational readiness
From study opportunity to active site
Central feasibility
Investigator fit, patient access, protocol requirements, and realistic enrollment potential.
Coordinated startup
Regulatory, budget, contract, central IRB, training, and activation support.
Study execution
Participant-centered visits, responsive communication, and quality-focused operations.
Enrolling now
Current clinical trial opportunities
Study listings and applications are securely powered by the existing Wellness Clinical Research trial platform.
Blog & News
Research updates worth reading
Meaningful Wellness milestones and practical perspectives from the clinical research site level.
AI Can Find Trial Candidates. Can Your Site Convert the Referral?
Recent AI recruitment announcements are shifting attention toward faster patient identification. The harder operational question is whether sites can review, contact, qualify, and support those referrals without losing participants in the handoff.
Read more
The Startup Bottleneck Hiding Between Site Activation and First Patient In
Recent industry attention has focused on a frequently overlooked part of study startup: translating the protocol and supporting manuals into source documents that staff can reliably use. Here is why that work delays enrollment, creates quality risk, and deserves earlier sponsor, CRO, and site coordination.
Read more
The Lab Result Is Not the Cohort: Operational Lessons From FDA’s New Hepatic Impairment Guidance
FDA’s September 2026 draft guidance on hepatic impairment studies highlights a site-level problem that is easy to underestimate: finding patients with liver disease is not the same as enrolling participants who can be classified consistently, matched appropriately, and dosed on schedule.
Read moreStart a conversation
Bring your next study opportunity to Wellness
Discuss investigator fit, patient access, site capabilities, and placement in Miami, Vega Baja, or both.